| Vol. 18.38 – 11 October, 2023 |
| |
|
|
| Scientists presented quality, safety, and efficacy data supporting the first-in-human STEM-Parkinson’s disease (PD) phase I/IIa clinical trial along with the trial design. [Cell Stem Cell] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators described a protocol to assemble a complete mouse embryo model using mESCs and induced ESCs to express Cdx2 and Gata4 to reconstitute the epiblast, extraembryonic ectoderm, and visceral endoderm lineages, respectively. [Nature Protocols] |
|
|
|
| Using aged iPSC-derived cardiomyocytes, the authors studied the effect of cell age on the young extracellular matrix therapy, an emerging approach for myocardial infarction treatment and prevention. [Aging Cell] |
|
|
|
| Researchers developed a differentiation protocol by mimicking the two-stage development of hepatoblasts, which permited the efficient generation of hepatic progenitor cells from chemically induced iPSCs. [Cell Proliferation] |
|
|
|
| Scientists provided the first direct comparisons of the early human embryonic otocyst and fetal sensory organs with human inner ear organoids. [Development] |
|
|
|
| The authors examined the role of peptidylarginine deiminase IV (PADI4) in maintaining the multi-lineage differentiation potential of mouse ESCs. [Philosophical Transactions Of The Royal Society B-Biological Sciences] |
|
|
|
| Investigators assessed the ability of 8-cell blastomeres to produce epiblast cells and ESC lines after isolation, and the properties of the resulting lines. [Frontiers In Cell And Developmental Biology] |
|
|
|
| Researchers analyzed the human vascular endothelial cells by utilizing the isogenic pairs of T21-iPSCs and corrected disomy 21-iPSCs. [Human Molecular Genetics] |
|
|
|
| Scientists developed a human PSC-based system that modeled the human intramembranous ossification process. They found that spheroid culture of the hPSC-derived paraxial mesoderm derivatives generated osteoprogenitors or osteo-chondroprogenitors depending on stimuli. [Regenerative Therapy] |
|
|
|
|
| The authors evaluate the preparation of primary astrocytes (ACs), its limitations, as well as the importance of obtaining high-quality ACs. Additionally, they provide an updated review of the research progress in this field. [Developmental Neurobiology] |
|
|
|
|
| Andrew A. Wilson, MD, of Boston University (BU) Chobanian & Avedisian School of Medicine, has recently received a gift of $100,000 to establish the Katharine Howe Lovett Fund for Alpha-1 antitrypsin deficiency (AATD) Research. [Boston University] |
|
|
|
|
| November 28 – 30, 2023 San Francisco, California, United States |
|
|
|
|
|
| Luxembourg Centre for Systems Biomedicine – Luxembourg, Luxembourg |
|
|
|
| Kunming University of Science and Technology – Kunming, China |
|
|
|
| St. Anna Children’s Cancer Research Institute – Vienna, Austria |
|
|
|
| Medical University of South Carolina – Charleston, South Carolina, United States |
|
|
|
| The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
|